Stocks
Novo Nordisk (NVO) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 4.07 | 0.03 | -0.03 | 3.11 | 2.11 | 1.74 | ||
| Changes by years, y/y, % | +48% | -99% | -198% | -11 146% | -32% | -5.1% | |||
Novo Nordisk. EV/EBITDA
Novo Nordisk. EV/EBITDA, changes, %
Novo Nordisk (NVO) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | 2.34 | 2.24 | 1.87 | 2.03 | 1.55 | 1.74 | |
| Changes by years, y/y, % | +1 555% | -37 419% | -49% | -31% | -34% | |||
| Changes by quarters, q/q, % | -21% | -4% | -17% | +9% | -24% | |||
